Clincosm LogoSign in Get a demo

al amyloidosis

Showing 26 - 38 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AL Amyloidosis Trial in Boston (Pomalidomide, Dexamethasone)

Completed
Has Results
  • AL Amyloidosis
  • Boston, Massachusetts
    Boston Medical Center
Sep 3, 2020

AL Amyloidosis Trial in Boston (Venetoclax, Dexamethasone)

Terminated
  • AL Amyloidosis
  • Boston, Massachusetts
    Tufts Medical Center
Aug 19, 2020

AL Amyloidosis Trial in Boston, Detroit, New York (Bendamustine, Dexamethasone)

Completed
Has Results
  • AL Amyloidosis
  • Boston, Massachusetts
  • +5 more
Mar 17, 2020

AL Amyloidosis Trial in United States (NEOD001)

Terminated
Has Results
  • AL Amyloidosis
  • Stanford, California
  • +4 more
May 14, 2019

AL Amyloidosis, Amyloidosis Trial in South San Francisco (non-interventional)

Completed
  • AL Amyloidosis
  • Amyloidosis
  • non-interventional
  • South San Francisco, California
    Online registry
Apr 7, 2019

AL Amyloidosis Trial in Worldwide (NEOD001, Placebo)

Completed
Has Results
  • AL Amyloidosis
  • Duarte, California
  • +39 more
Apr 2, 2019

AL Amyloidosis Trial in Worldwide (NEOD001)

Terminated
Has Results
  • AL Amyloidosis
  • Duarte, California
  • +33 more
Mar 12, 2019

AL Amyloidosis Trial in Boston (Bortezomib, Melphalan, Neupogen)

Terminated
Has Results
  • AL Amyloidosis
  • Boston, Massachusetts
    Boston Medical Center
Aug 10, 2018

Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Boston (Haploidentical Bone

Unknown status
  • Chronic Kidney Disease
  • +16 more
  • Haploidentical Bone Marrow/Kidney
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 21, 2017

AL Amyloidosis Trial in Pavia (BMDex)

Completed
  • AL Amyloidosis
  • Pavia, Italy
    Amyloidosis Research and Treatment Center
Mar 9, 2017

AL Amyloidosis Trial in France, Germany, Switzerland

Completed
  • AL Amyloidosis
    • Limoges, France
    • +3 more
    Jul 23, 2015

    AL Amyloidosis Trial in Knoxville (Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg))

    Completed
    • AL Amyloidosis
    • Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg)
    • Knoxville, Tennessee
      University of Tennessee Medical Center
    Sep 17, 2013

    AL Amyloidosis Trial in Knoxville (124I-labeled mAb Mu 11-1F4)

    Completed
    • AL Amyloidosis
    • 124I-labeled monoclonal antibody Mu 11-1F4
    • Knoxville, Tennessee
      University of Tennessee Medical Center
    Oct 10, 2012